Literature DB >> 7468610

Effect of diuresis on the performance of the failing left ventricle in man.

J R Wilson, N Reichek, W B Dunkman, S Goldberg.   

Abstract

To determine the effect of diuresis on the performance of the failing left ventricle, we measured cardiac output, pulmonary wedge pressure and M-mode echo left ventricular diastolic dimension before and after diuresis in 13 patients with heart failure. Diuresis increased stroke volume (43 +/- 23 ml to 50 +/- 18 ml (p less than 0.05)) and decreased pulmonary wedge pressure (28 +/- 3 mm Hg to 19 +/- 5 mm Hg (p less than 0.01)), mean blood pressure (100 +/- 14 mm Hg to 88 +/- 10 mm Hg (p less than 0.01)) and systemic vascular resistance (2,059 +/- 622 dynes-sec-cm-5 to 1,783 +/- 556 dynes-sec-cm-5 (p less than 0.05)). Echo left ventricular diastolic dimension was not changed by diuresis (6.0 +/- 0.8 cm to 6.0 +/- 0.8 cm). Percent change in stroke volume correlated with systemic vascular resistance (r = 0.60, p less than 0.05) and with left ventricular diastolic dimension (r = 0.62, p less than 0.05) but not with pulmonary wedge pressure (r = 0.12) or right atrial pressure (r = 0.04). Thus, diuresis improved the performance of the failing ventricle and reduced afterload, but it did not alter left ventricular diastolic dimension, an index of preload. These data suggest that diuresis improves ventricular function by decreasing afterload.

Entities:  

Mesh:

Year:  1981        PMID: 7468610     DOI: 10.1016/0002-9343(81)90755-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  18 in total

Review 1.  Diuretics for respiratory distress syndrome in preterm infants.

Authors:  Audra Stewart; Luc P Brion; Roger Soll
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

Review 2.  Outpatient management of congestive heart failure.

Authors:  E K Massin
Journal:  Tex Heart Inst J       Date:  1998

Review 3.  Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.

Authors:  Audra Stewart; Luc P Brion
Journal:  Cochrane Database Syst Rev       Date:  2011-09-07

Review 4.  Heart failure therapy at the turn of the century.

Authors:  S Goldstein
Journal:  Heart Fail Rev       Date:  2001-01       Impact factor: 4.214

Review 5.  WITHDRAWN: Diuretics for heart failure.

Authors:  Rajaa F Faris; Marcus Flather; Henry Purcell; Philip A Poole-Wilson; Andrew J S Coats
Journal:  Cochrane Database Syst Rev       Date:  2016-04-04

6.  Fluid Management in Patients with Chronic Heart Failure.

Authors:  Pierpaolo Pellicori; Kuldeep Kaur; Andrew L Clark
Journal:  Card Fail Rev       Date:  2015-10

Review 7.  Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers.

Authors:  J Malcom O Arnold; Jonathan G Howlett; Paul Dorian; Anique Ducharme; Nadia Giannetti; Haissam Haddad; George A Heckman; Andrew Ignaszewski; Debra Isaac; Philip Jong; Peter Liu; Elizabeth Mann; Robert S McKelvie; Gordon W Moe; John D Parker; Anna M Svendsen; Ross T Tsuyuki; Kelly O'Halloran; Heather J Ross; Vivek Rao; Errol J Sequeira; Michel White
Journal:  Can J Cardiol       Date:  2007-01       Impact factor: 5.223

Review 8.  Results of clinical trials with diuretics in heart failure.

Authors:  J R Hampton
Journal:  Br Heart J       Date:  1994-08

9.  Diuretic therapy in congestive heart failure for the elderly patient.

Authors:  E T Carvalho Filho
Journal:  Drugs       Date:  1986       Impact factor: 9.546

10.  Acute and chronic effects of a diuretic monotherapy with piretanide in congestive heart failure--a placebo-controlled trial.

Authors:  W Haerer; U Bauer; N Sultan; K Cernoch; N Mouselimis; K J Fehske; M Hetzel; M Stauch; V Hombach
Journal:  Cardiovasc Drugs Ther       Date:  1990-04       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.